Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹27,165.00
395.00 (1.48%)
Medium VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹57.72K Cr
MID CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
N/A
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹25,150+8.0%
52W High₹35,310-23.1%
Current Price
₹27,165.00
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹21,732.00
Upper Circuit₹32,598.00
Reference Price
₹27,165.00
Investment Checklist
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹27010.0
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹26915.0
News: Abbott India Ltd gains for fifth session...
10/20 Bullish Cross detected 1 day(s) ago
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-11
Confidence
81%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition | Bearish MA stack (20<50<200)
EMA20
26263.54
EMA50
26318.98
EMA200
27987.32
Price Action
UPTREND
BULLISH
Higher Highs6
Higher Lows7
Lower Highs2
Lower Lows2
Support & Resistance Levels
Resistance (Above)
₹27430.00
₹28456.67
₹29155.00
₹29587.50
₹30515.00
Support (Below)
₹27100.00
₹26351.67
₹25695.00
₹25235.00
Volume Analysis
TrendINCREASING
Change+57.70%
Unusual VolumeNo
Recent MA Crossovers
10/20 Bullish Cross
1 day ago
BUY
Stop Loss Levels
Fixed Risk
1% Risk₹26893.35
3% Risk₹26350.05
5% Risk₹25806.75
7% Risk (Custom)
₹25263.45Technical Levels
1x ATR (Volatility)₹26603.44
2x ATR (Swing)₹26041.88
3x ATR (Trend)₹25480.32
Immediate Support₹27100.00
Moving Averages
EMA 9 (Short-term)₹26441.79
EMA 20 (Medium-term)₹26263.54
EMA 50 (Trend)₹26318.98
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹1,602.4 Cr | ₹1,738.4 Cr | ₹1,757.2 Cr | ₹1,724 Cr |
| Net Profit | ₹367 Cr | ₹365.9 Cr | ₹415.3 Cr | ₹376 Cr |
| EPS | — | ₹172.17 | ₹195.42 | ₹176.92 |
| Operating Profit | ₹504.6 Cr | ₹518.4 Cr | ₹572.1 Cr | ₹533.2 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.7 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.6 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 22.8 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.3 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.1 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.1 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 25.7 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 93.4 | ₹83.02K Cr mid Cap | |
| Abbott India Limited | ₹27,165.00 | +1.48% | — | ₹57.72K Cr mid Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 25 Jul 2025 | Dividend - Rs 475 Per Share | DIVIDEND |
| 19 Jul 2024 | Dividend - Rs 410 Per Share | DIVIDEND |
| 21 Jul 2023 | Dividend - Rs 180 Per Share/ Special Dividend Rs 145 Per Share | SPECIAL_DIVIDEND |
| 02 Aug 2022 | Annual General Meeting/Dividend - Rs 145 Per Share/Special Dividend- 130 Per Share | AGM |
| 19 Jul 2021 | Annual General Meeting/Dividend - Rs 120 Per Share Special Dividend 155 Per Share | AGM |
Board Meetings
Upcoming and past meetings
| Date | Purpose | Links |
|---|---|---|
| 25 Sept 2002 | Unaudited Financial Results | - |
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for ABBOTINDIA
View AllNEWS
positive
Business Standard - Markets 5d ago
Abbott India Ltd gains for fifth session
Abbott India Ltd is quoting at Rs 26830, up 3.61% on the day as on 12:44 IST on the NSE. The stock is down 22.2% in last one year as compared to a 3.99% gain in NIFTY and a 15.09% gain in the Nifty Pharma.
ABBOTINDIAAONELIQUIDAONENIFTYAONETMMQ50AONETOTALPHARMABEESFinancial ServicesHealthcare
NEWS
positive
Business Standard - Markets 37d ago
Abbott India Ltd drops for fifth straight session
Abbott India Ltd is quoting at Rs 26020, down 1.03% on the day as on 13:19 IST on the NSE. The stock jumped 5.41% in last one year as compared to a 5.65% slide in NIFTY and a 11.71% spurt in the Nifty Pharma index.
ABBOTINDIAAONELIQUIDAONENIFTYAONETMMQ50AONETOTALBANKIETFPHARMABEESPVTBANIETFFinancial ServicesHealthcare
NEWS
positive
Business Standard - Markets 60d ago
Abbott India clocks PAT of Rs 394.93 crore in March'26 quarter
Abbott India has reported 7.6% increase in consolidated net profit to Rs 394.93 crore on a 6.5% rise in revenue to Rs 1,709.51 crore in Q4 FY26 as compared with Q4 FY25.
ABBOTINDIAHealthcare